Molecular mechanisms for CMT1A duplication and HNPP deletion

被引:33
作者
Boerkoel, CF
Inoue, K
Reiter, LT
Warner, LE
Lupski, JR
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
来源
CHARCOT-MARIE-TOOTH DISORDERS | 1999年 / 883卷
关键词
D O I
10.1111/j.1749-6632.1999.tb08563.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As the best characterized human genomic disorders,(118) CMT1A and HNPP illustrate several common mechanistic features of genomic rearrangements. These features include the following: (1) Recombination occurs between homologous sequences flanking the duplitated/deleted genomic segment. (2) The evolution of the mammalian genome may result in an architecture consisting of region-specific low-copy repeats that predispose to rearrangement secondary to providing homologous regions as substrate for recombination. (3) Strand exchange occurs preferentially in a region of perfect sequence identity within the flanking repeat sequences, (4) Double-strand breaks likely initiate recombination between the flanking repeats. (5) The mechanism and rate of homologous recombination resulting in DNA rearrangement may differ for male and female gametogenesis. (6) Homologous recombination resulting in DNA rearrangement occurs with high frequency in the human genome, (7) Genomic disorders result from structural features of the human genome and not population specific alleles or founder effects; therefore, genomic disorders appear to occur with equal frequencies in different world populations.
引用
收藏
页码:22 / 35
页数:14
相关论文
共 123 条
  • [1] Adlkofer K, 1997, J NEUROSCI, V17, P4662
  • [2] HYPERMYELINATION AND DEMYELINATING PERIPHERAL NEUROPATHY IN PMP22-DEFICIENT MICE
    ADLKOFER, K
    MARTINI, R
    AGUZZI, A
    ZIELASEK, J
    TOYKA, KV
    SUTER, U
    [J]. NATURE GENETICS, 1995, 11 (03) : 274 - 280
  • [3] Roussy-Levy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2
    Auer-Grumbach, M
    Strasser-Fuchs, S
    Wagner, K
    Körner, E
    Fazekas, F
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 154 (01) : 72 - 75
  • [4] BAIRD PN, 1992, ONCOGENE, V7, P2141
  • [5] 2 FAMILIES OF LOW-COPY-NUMBER REPEATS ARE INTERSPERSED ON XP22.3 - IMPLICATIONS FOR THE HIGH-FREQUENCY OF DELETIONS IN THIS REGION
    BALLABIO, A
    BARDONI, B
    GUIOLI, S
    BASLER, E
    CAMERINO, G
    [J]. GENOMICS, 1990, 8 (02) : 263 - 270
  • [6] Blair IP, 1996, AM J HUM GENET, V58, P472
  • [7] BROWN KW, 1992, ONCOGENE, V7, P763
  • [8] OVEREXPRESSION OF DM20 MESSENGER-RNA IN 2 BROTHERS WITH PELIZAEUS-MERZBACHER-DISEASE
    CARANGO, P
    FUNANAGE, VL
    QUIROS, RE
    DEBRUYN, CS
    MARKS, HG
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (04) : 610 - 617
  • [9] TRISOMY-17P ASSOCIATED WITH CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1A PHENOTYPE - EVIDENCE FOR GENE DOSAGE AS A MECHANISM IN CMT1A
    CHANCE, PF
    BIRD, TD
    MATSUNAMI, N
    LENSCH, MW
    BROTHMAN, AR
    FELDMAN, GM
    [J]. NEUROLOGY, 1992, 42 (12) : 2295 - 2299
  • [10] DNA DELETION ASSOCIATED WITH HEREDITARY NEUROPATHY WITH LIABILITY TO PRESSURE PALSIES
    CHANCE, PF
    ALDERSON, MK
    LEPPIG, KA
    LENSCH, MW
    MATSUNAMI, N
    SMITH, B
    SWANSON, PD
    ODELBERG, SJ
    DISTECHE, CM
    BIRD, TD
    [J]. CELL, 1993, 72 (01) : 143 - 151